Investor & Media Relations

We discover and develop medicines to defeat neurodegeneration.

The science is breaking open and the time is right for an ambitious and rigorous effort to address Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases. We are applying deep scientific and drug development expertise to discover effective molecular therapeutics and have engineered a proprietary technology to deliver biologic therapeutics to the brain.

With a team of experienced and passionately dedicated scientists and drug developers, we believe we can succeed in meaningfully improving the lives of patients and their families.

Denali Nasdaq

Press Releases

Events

Analyst Coverage

View detailed list of firms and analysts.

View Coverage

SEC Filing

View, download, and share all SEC Filing documents.

View Documents

Corporate Governance

View, download, and share Corporate Governance documents.

View Documents

FAQs

    Denali Therapeutics Inc. was incorporated in Delaware in October 2013

    Denali is headquartered in South San Francisco, CA.

    Denali's fiscal year ends December 31st

    Ernst & Young LLP is Denali's independent registered public accounting firm

    Denali is traded on the NASDAQ Global Select Stock Market under the ticker symbol "DNLI"

    Denali initial public offering occurred on December 8, 2017

    24823R 105

    American Stock Transfer & Trust Company

    (800) 937-5449 (Toll-free)

    (718) 921-8124 (International)

    info@amstock.com http://www.amstock.com/new/Inv...

    American Stock Transfer & Trust Company Operations Center

    6201 15th Avenue

    Brooklyn, NY 11219

    Electronic copies of our Annual Report and other periodic reports are available on this website. If you would like to request paper copies of the Annual Report or other periodic reports, send your request in writing to:

    Denali Therapeutics Inc.

    Attn: Corporate Secretary

    151 Oyster Point Blvd

    South San Francisco, CA 94080

    Please use the Contact form for additional questions or inquiries.

    Sign up for email alerts

    Stay in the loop with updates on the latest Denali news delivered right to your inbox

    Required fields denoted by an asterisk (*).